We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Paradoxical hidradenitis suppurativa induced by adalimumab biosimilar successfully treated with guselkumab in a patient with psoriasis. Comment on 'Paradoxical hidradenitis suppurativa due to anti-interleukin-1 agents for mevalonate kinase deficiency successfully treated with the addition of ustekinumab'
- Authors
Martora, Fabrizio; Fabbrocini, Gabriella; Marasca, Claudio; Battista, Teresa; Megna, Matteo
- Abstract
Comment on 'Paradoxical hidradenitis suppurativa due to anti-interleukin-1 agents for mevalonate kinase deficiency successfully treated with the addition of ustekinumab' Google Scholar Crossref Search ADS PubMed WorldCat 8 Berman HS, Villa NM, Shi VY, Hsiao JL. Guselkumab in the treatment of concomitant hidradenitis suppurativa, psoriasis, and Crohn's disease. Paradoxical hidradenitis suppurativa induced by adalimumab biosimilar successfully treated with guselkumab in a patient with psoriasis.
- Subjects
HIDRADENITIS suppurativa; MEVALONATE kinase; TREATMENT effectiveness; PSORIASIS; PSORIATIC arthritis; ADALIMUMAB; IMMUNE reconstitution inflammatory syndrome
- Publication
Clinical & Experimental Dermatology, 2023, Vol 48, Issue 6, p701
- ISSN
0307-6938
- Publication type
Article
- DOI
10.1093/ced/llad082